BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9680368)

  • 21. Immunostimulatory CpG-oligonucleotides cause proliferation, cytokine production, and an immunogenic phenotype in chronic lymphocytic leukemia B cells.
    Decker T; Schneller F; Sparwasser T; Tretter T; Lipford GB; Wagner H; Peschel C
    Blood; 2000 Feb; 95(3):999-1006. PubMed ID: 10648415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival of leukemic B cells promoted by engagement of the antigen receptor.
    Bernal A; Pastore RD; Asgary Z; Keller SA; Cesarman E; Liou HC; Schattner EJ
    Blood; 2001 Nov; 98(10):3050-7. PubMed ID: 11698290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction with vascular endothelium enhances survival in primary chronic lymphocytic leukemia cells via NF-kappaB activation and de novo gene transcription.
    Buggins AG; Pepper C; Patten PE; Hewamana S; Gohil S; Moorhead J; Folarin N; Yallop D; Thomas NS; Mufti GJ; Fegan C; Devereux S
    Cancer Res; 2010 Oct; 70(19):7523-33. PubMed ID: 20736369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Constitutive activation of NF-kappaB in primary adult T-cell leukemia cells.
    Mori N; Fujii M; Ikeda S; Yamada Y; Tomonaga M; Ballard DW; Yamamoto N
    Blood; 1999 Apr; 93(7):2360-8. PubMed ID: 10090947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. c-Abl kinase inhibitors overcome CD40-mediated drug resistance in CLL: implications for therapeutic targeting of chemoresistant niches.
    Hallaert DY; Jaspers A; van Noesel CJ; van Oers MH; Kater AP; Eldering E
    Blood; 2008 Dec; 112(13):5141-9. PubMed ID: 18796631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Matrix metalloproteinase-9 is involved in chronic lymphocytic leukemia cell response to fludarabine and arsenic trioxide.
    Amigo-Jiménez I; Bailón E; Ugarte-Berzal E; Aguilera-Montilla N; García-Marco JA; García-Pardo A
    PLoS One; 2014; 9(6):e99993. PubMed ID: 24956101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NF-kappaB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes.
    Lee HH; Dadgostar H; Cheng Q; Shu J; Cheng G
    Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9136-41. PubMed ID: 10430908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of IL-4 level by fludarabine and its relation to apoptosis in chronic B-cell lymphocytic leukemia.
    Shamaa LA; Hussein Ael-S; Balbaa OA; Farahat NM; Ali MA
    Egypt J Immunol; 2008; 15(1):181-92. PubMed ID: 20306682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NF-kappaB/p50 and NF-kappaB/c-Rel differentially regulate the activity of the 3'alphaE-hsl,2 enhancer in normal murine B cells in an activation-dependent manner.
    Zelazowski P; Shen Y; Snapper CM
    Int Immunol; 2000 Aug; 12(8):1167-72. PubMed ID: 10917891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of monocyte chemoattractant protein 1, but not IL-8, by alprazolam: effect of alprazolam on c-Rel/p65 and c-Rel/p50 binding to the monocyte chemoattractant protein 1 promoter region.
    Oda T; Ueda A; Shimizu N; Handa H; Kasahara T
    J Immunol; 2002 Sep; 169(6):3329-35. PubMed ID: 12218154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD40, but not lipopolysaccharide and anti-IgM stimulation of primary B lymphocytes, leads to a persistent nuclear accumulation of RelB.
    Neumann M; Wohlleben G; Chuvpilo S; Kistler B; Wirth T; Serfling E; Schimpl A
    J Immunol; 1996 Dec; 157(11):4862-9. PubMed ID: 8943389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microenvironmental stromal cells abrogate NF-κB inhibitor-induced apoptosis in chronic lymphocytic leukemia.
    Simon-Gabriel CP; Foerster K; Saleem S; Bleckmann D; Benkisser-Petersen M; Thornton N; Umezawa K; Decker S; Burger M; Veelken H; Claus R; Dierks C; Duyster J; Zirlik K
    Haematologica; 2018 Jan; 103(1):136-147. PubMed ID: 29122993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis B virus HBx protein activates transcription factor NF-kappaB by acting on multiple cytoplasmic inhibitors of rel-related proteins.
    Su F; Schneider RJ
    J Virol; 1996 Jul; 70(7):4558-66. PubMed ID: 8676482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergistic Activity of Deguelin and Fludarabine in Cells from Chronic Lymphocytic Leukemia Patients and in the New Zealand Black Murine Model.
    Rebolleda N; Losada-Fernandez I; Perez-Chacon G; Castejon R; Rosado S; Morado M; Vallejo-Cremades MT; Martinez A; Vargas-Nuñez JA; Perez-Aciego P
    PLoS One; 2016; 11(4):e0154159. PubMed ID: 27101369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer.
    Sovak MA; Bellas RE; Kim DW; Zanieski GJ; Rogers AE; Traish AM; Sonenshein GE
    J Clin Invest; 1997 Dec; 100(12):2952-60. PubMed ID: 9399940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maintenance of nuclear factor-kappa B/Rel and c-myc expression during CD40 ligand rescue of WEHI 231 early B cells from receptor-mediated apoptosis through modulation of I kappa B proteins.
    Schauer SL; Wang Z; Sonenshein GE; Rothstein TL
    J Immunol; 1996 Jul; 157(1):81-6. PubMed ID: 8683159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD40 ligation conditions dendritic cell antigen-presenting function through sustained activation of NF-kappaB.
    O'Sullivan BJ; Thomas R
    J Immunol; 2002 Jun; 168(11):5491-8. PubMed ID: 12023343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CpG DNA rescue from anti-IgM-induced WEHI-231 B lymphoma apoptosis via modulation of I kappa B alpha and I kappa B beta and sustained activation of nuclear factor-kappa B/c-Rel.
    Yi AK; Krieg AM
    J Immunol; 1998 Feb; 160(3):1240-5. PubMed ID: 9570540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amifostine inhibits hematopoietic progenitor cell apoptosis by activating NF-kappaB/Rel transcription factors.
    Romano MF; Lamberti A; Bisogni R; Garbi C; Pagnano AM; Auletta P; Tassone P; Turco MC; Venuta S
    Blood; 1999 Dec; 94(12):4060-6. PubMed ID: 10590050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phenylarsine oxide blocks interleukin-1beta-induced activation of the nuclear transcription factor NF-kappaB, inhibits proliferation, and induces apoptosis of acute myelogenous leukemia cells.
    Estrov Z; Manna SK; Harris D; Van Q; Estey EH; Kantarjian HM; Talpaz M; Aggarwal BB
    Blood; 1999 Oct; 94(8):2844-53. PubMed ID: 10515888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.